The Gross Law Firm Reminds Picard Medical, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 3, 2026 - PMI

Core Viewpoint - The Gross Law Firm has announced a class action lawsuit against Picard Medical, Inc. (NYSE: PMI) for allegedly misleading shareholders during a specified class period, with a lead plaintiff deadline set for April 3, 2026 [1]. Group 1: Allegations - The lawsuit claims that during the class period from September 2, 2025, to October 31, 2025, Picard Medical, Inc. made materially false and misleading statements [1]. - Allegations include involvement in a fraudulent stock promotion scheme utilizing social media misinformation and impersonation of financial professionals [1]. - It is also alleged that insiders used offshore or nominee accounts to facilitate coordinated share dumping during a price inflation campaign [1]. - The company's public statements and risk disclosures reportedly omitted critical information regarding false rumors and artificial trading activity affecting stock prices [1]. Group 2: Next Steps for Shareholders - Shareholders who purchased PMI shares during the specified timeframe are encouraged to register for the class action to potentially become lead plaintiffs [1]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [1]. - Participation in the case incurs no cost or obligation for the shareholders [1].